版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
粘液表皮樣癌、腺樣囊性癌,腺泡細(xì)胞癌和上皮-肌上皮癌陳國璋MucoepidermoidcarcinomaAciniccellcarcinomaAdenoidcysticcarcinoma黏液表皮樣癌癌細(xì)胞引人注目的特征:-鱗狀細(xì)胞-粘液細(xì)胞-不確定型細(xì)胞(中間細(xì)胞)無痛性緩慢增長,實(shí)性腫塊黏液表皮樣癌大體觀邊界不清的腫塊(可有囊性變)質(zhì)地韌或硬囊腫常見囊腫內(nèi)可有黏液黏液表皮樣癌組織學(xué)浸潤性多個(gè)不規(guī)則腫瘤細(xì)胞巢纖維性/促結(jié)締組織增生性間質(zhì)伴有炎癥細(xì)胞浸潤上皮細(xì)胞巢實(shí)性或囊性(充滿分泌物)粘液外滲黏液表皮樣癌的細(xì)胞類型1、粘液分泌細(xì)胞(柱狀或杯狀狀)2、表皮樣細(xì)胞
-多邊形,胞漿呈淡嗜酸性-幾乎看不到細(xì)胞間橋或角化-幾乎沒有明確鱗化!3、中間型細(xì)胞細(xì)胞形態(tài)更小鑲嵌狀排列在黏液細(xì)胞下
黏液表皮樣癌的細(xì)胞發(fā)生涎腺導(dǎo)管儲(chǔ)備細(xì)胞中間型細(xì)胞表皮樣細(xì)胞SquamouscellMucouscellClearcellP63免疫組化常常陽性!黏液表皮樣癌:變型透明細(xì)胞(含有豐富的糖原)嗜酸性細(xì)胞梭形細(xì)胞生長硬化型透明細(xì)胞嗜酸性細(xì)胞梭形細(xì)胞硬化黏液表皮樣癌黏液進(jìn)入囊內(nèi),形成微囊或大囊黏液滲出慢性炎癥反應(yīng)纖維化高級(jí)別腫瘤不突出!!黏液滲出粘液表皮樣癌:傳統(tǒng)的三層分級(jí)系統(tǒng)低級(jí)別中級(jí)別高級(jí)別許多微囊和大囊一些囊少數(shù)囊許多黏液細(xì)胞混合性細(xì)胞少量黏液細(xì)胞很少核分裂核分裂不常見很多核分裂溫和的細(xì)胞形態(tài)有一定的異型性細(xì)胞多形性LGHGHGPASDLGIG黏液表皮樣癌的過度診斷Warthin瘤鱗化和/或黏液上皮化生(如果一個(gè)溫和的腫瘤有很多的鱗狀表現(xiàn),它就不是一個(gè)黏液表皮樣癌)囊腺瘤(非浸潤性和單型細(xì)胞)壞死性涎腺化生Warthin瘤伴鱗化多形性腺瘤多形性腺瘤壞死性涎腺化生黏液表皮樣癌診斷不足缺乏腫瘤細(xì)胞島和黏液外滲,誤診為黏液囊腫溫和的細(xì)胞,誤診為良性腫瘤囊性變占大部分的腫瘤(誤為囊腺瘤)硬化和炎癥占主要部分(誤診為炎癥性病變)大涎腺不明原因的黏液池伴炎癥黏液表皮樣癌,除非被證實(shí)為其它黏液表皮樣癌
診斷檢查表浸潤性邊界硬化性間質(zhì)(常見)慢性炎癥細(xì)胞浸潤(常見)特征性上皮島/巢如果有明顯的鱗狀上皮或角化,大概就不是黏液表皮樣癌了。腺泡細(xì)胞癌定義:上皮性腫瘤顯示向細(xì)胞腺泡細(xì)胞分化主要發(fā)生在腮腺極少發(fā)生在小涎腺慢性生長的腫瘤,有或無痛可能是雙側(cè)性的(常見)腺泡細(xì)胞癌:
病理常常是局限性的,偶爾是多結(jié)性的或浸潤性的實(shí)性或囊性通常是混合生長模式通常混合細(xì)胞形態(tài)(核分裂少見)間質(zhì)通常不明顯可能有突出的淋巴細(xì)胞聚集腺泡細(xì)胞癌:
生長模式微囊型**
腺泡群或簇實(shí)性(常呈器官樣)乳頭狀囊性(常富含空泡、鞋釘、閏管及非特異性腺細(xì)胞)濾泡(類似甲狀腺濾泡)腺泡細(xì)胞癌:
細(xì)胞類型腺泡細(xì)胞(偏位的暗的核,嗜堿性胞漿)閏管樣細(xì)胞(小立方形細(xì)胞;中位核;粉紅色細(xì)胞質(zhì))–可占主導(dǎo)地位空泡細(xì)胞(大小類似于腺泡細(xì)胞;單個(gè)或多個(gè)空泡)非特異性腺細(xì)胞(通常是模糊的細(xì)胞邊界;中位核)透明細(xì)胞(不常見,糖原陰性)沒有肌上皮/基底細(xì)胞,P63陰性正常的腺泡和閏管CKSomepeculiarfeaturesof
aciniccellcarcinomaSelf-destructivequalityinsome:ischemiaandnecrosis--->SolitaryorloculatedcystswithpapillaeandhydropicclearcellsLipogranulomatousreactionInfarctafterFNABUnderdiagnosisofaciniccellcarcinomaSomeaciniccellcarcinomasarepredominantlycystic--canbemistakenforbenignsalivarycystAciniccellcarcinoma:behaviorLowgrade,indolentmalignancyGradingorhistologicvarianthasnoprognosticsignificanceRecurrence35%(maybedelayedto30yr)Metastasis16-19%(oftendelayedaftermanyyears)LymphnodeDistant(lungs,bone)Survival:5-yr90%;20-yr56%Aciniccellcarcinoma:
unfavorableprognosticfactorsGrossinvasionHighstagediseaseDesmoplasiaSignificantcellularatypiaIncreasedmitoticactivityorMIB1index(>5%:62%unfavorableoutcome)JPathol1994;173:13-21DedifferentiatedaciniccellcarcinomaAtypiaDedifferentiatedaciniccellCAAciniccellcarcinoma:
favorableprognosticfactorsSmallsize(<3cm)RichinlymphoidstromaHumPathol1997;28:595-600Adequateinitialexcision**(recurrence11%,versus>90%forincompleteexcision)Aciniccellcarcinoma:
essenceofdiagnosisIdentificationofaciniccelldifferentiationinthetumorcells(whichisoftenfocal)Canbehelpedby:PAS-diastasestain(intracytoplasmicgranules)Amylaseimmunohistochemistry(notreadilyavailable)Onlyluminalcell,butnotabluminalcell,differentiationADENOIDCYSTICCARCINOMAAninfiltrativecarcinomahavingvariousfeaturesofthreegrowthpatterns:glandular(cribriform),tubularorsolidTwocelltype:ductal-liningcellsmyoepithelial/basaltypecellsUsuallyaslow-growingtumorBoneinvasionmayoccurwithoutradiologicalevidenceAdenoidcysticcarcinoma:pathologyGross:Invasiveborders;solidappearanceTubules,cribriformstructures,solidmassesVariableamountsofhyalinizedstroma(sometimes“drowning”thetumor)Mayhavelattice-likepattern,andabundantstromalmucin/hyalinematerialPerineuralinvasionischaracteristic(butnotessentialfordiagnosis)Adenoidcysticcarcinoma:
celltypesDuctalepitheliumCuboidalSurroundsdistinctsmalllumina(oftenwitheosinophilicsecretion)Eosinophiliccytoplasm;vesicularnucleiCanbedifficulttoappreciateSmallbasaloidcells(modifiedmyoepithelium)OftenpredominantHyperchromaticnucleiIndistinctcellbordersOftenassociatedwithbasementmembranematerial,hyalinematerialorstromalmucinPseudocysts/stromalinclusionsc-kitp63SMAAdenoidcysticcarcinoma:geneticsAdistinctivechromosomaltranslocationrecentlyrecognizedinadenoidcysticcarcinoma:t(6;9)(q22-23;p23-24),resultinginMYB-NFIBfusionThisisfoundin50-86%ofallcases,butnotinothersalivaryglandtumorsInfuture,detectionofthemolecularalterationmayaidinthediagnosisofthistumortypeAdenoidcysticcarcinoma:grading
(M.D.Anderson)Grade1Grade2Grade3Tubularandcribriform,withnosolidareasPurecribriformormixedbutwith<30%solid>30%solidareas;necrosiscommon;morecellularatypiaUsuallysmallandamendabletototalsurgicalexcision.Protractedcourse.IntermediatebehaviorLargertumors.Frequentlyrecur(early).Oftenkillingwithin4yrs.15-yrsurvival39%26%5%Adenoidcysticcarcinoma:behaviorLocalinvasionMayextendforlongdistancealongnervesUsuallyslowlyprogressivecourse(dependingongrade)FrequentrecurrenceMetastasis30-40%(LN,lungs,bone)MajorityofpatientseventuallysuccumbtodiseaseafterprolongedclinicalcourseAdenoidcysticcarcinoma:
prognosticfactorsSize(betterif<2cm)Histologicgrade/presenceofsolidcomponentStageofdiseaseBoneinvasion(unfavorable)CompletenessofexcisionPresenceofdedifferentiation(worsenedprognosis)p63Adenoidcysticcarcinoma:checklistfordiagnosisInvasivebordersTwo-celltype(ductalepitheliummaybedifficulttofind)VariableamountsofbasementmembraneandhyalinematerialCribriformstructuresoftenpresentClearcellsveryrareProblemsindiagnosisof
adenoidcysticcarcinomaMorphologicoverlapwithotherentitieswithdual-celltypearchitecture:Pleomorphicadenoma,basalcelladenomaEpithelial-myoepithelialcarcinomaBasalcelladenocarcinomaSolidareasmaynotbediagnostic:needtosearchforinterspersedtubulesMarkedstromalhyalinizationrendersrecognitiondifficultAdenoidcysticcarcinomaBasalcell/pleomorphicadenomaBordersInfiltrativeCircumscribedCribriformpatternVerycommonRare(butcanoccur)ChondroidmatrixAbsentCommoninpleomorphicadenomaSpindlystromafocallyAbsentDiagnosticofbasalcellorpleomorphicadenoma“Melting”intostromaAbsent(buthyalinizationmaymimic“melting”)DiagnosticofpleomorphicadenomaPleomorphicadenomaS100BasalcelladenomaAdenoidcysticcarcinomaOthersalivarytumorsCD43/L60clone(Woo,2006)100%7%PLGA12%MonomorphicadenomaCD43/MT1clone(Seethala,2004)48%0%CD43Adenoidcysticcarcinoma:DiagnosisDon’t
makeadiagnosisofadenoidcysticcarcinomaifthereisnoinvasion!EPITHELIAL-MYOEPITHELIALCARCINOMACalled“clearcelladenoma”inthepastDefinition:Variableproportionsoftwocelltypeswhichtypicallyformductalstructures:innerlayerofductalcellsandouterlayerofclear(myoepithelial)cellsMostcommoninparotidEpithelial-myoepithelialcarcinoma:histologyUsuallymultinodularorpartlyencapsulatedInvadesinbroadfrontsDuctalepithelium:pinkcytoplasm;lumenmaycontaineosinophilicsecretion;mayformbranchingluminaOuterlayerofmyoepitheliumhasclearcytoplasm(Glycogen+;S100protein+;Actin+;Myosin+;p63+);oftenassociatedwiththickB.M.orhyalinematerialEpithelial-myoepithelialcarcinoma:histologyBiphasicpatternmaynotbeobviousinsomecases:anastomosingislandsandlargesheetsofclearcells(whichcanevenbecomespindly,withfasciculargrowth),onlyoccasionalinterspersedtubulesVariableamountsofhyalinizedstromaPerineuralandvascularinvasionsometimesseenPASPASDCD117p63SMAEpithelial-myoepithelialcarcinoma:behaviorLowgrade,indolenttumorMayevolvetoamyoepithelialcarcinomaRecurrence30-40%(canberepeated)CervicalLNmetastasis10-20%Distantmetastasis9%Tumormortality9%Epithelial-myoepithelialcarcinoma:D.Dx.AdenoidcysticCAMorepermeativebordersAbluminalcellsmuchsmaller(“basaloid”)ClearcellsrareFrequentcribriformstructureswithbasophilicmucinBranchinglumensrarePle
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年度醫(yī)院物業(yè)委托管理與維護(hù)合同4篇
- 2025年度個(gè)人向公司借款用于投資合作合同范本2篇
- 2025年度影視作品制作及版權(quán)運(yùn)營合同3篇
- 2024版院長聘用合同
- 2024裝修樣板間保密協(xié)議
- 2025年度智能家居產(chǎn)品承包加工合同4篇
- 2025年度智慧社區(qū)車位出售及智能停車解決方案合同4篇
- 2025年度咖啡館股權(quán)置換及品牌輸出合同3篇
- 2025年復(fù)雜斷塊油田項(xiàng)目可行性研究報(bào)告
- 2025年度體育場(chǎng)館運(yùn)營管理承包服務(wù)合同范本4篇
- 人教版(2025新版)七年級(jí)下冊(cè)英語:寒假課內(nèi)預(yù)習(xí)重點(diǎn)知識(shí)默寫練習(xí)
- 藝術(shù)品捐贈(zèng)協(xié)議
- 【公開課】同一直線上二力的合成+課件+2024-2025學(xué)年+人教版(2024)初中物理八年級(jí)下冊(cè)+
- 高職組全國職業(yè)院校技能大賽(嬰幼兒照護(hù)賽項(xiàng))備賽試題庫(含答案)
- 2024年公安部直屬事業(yè)單位招聘筆試參考題庫附帶答案詳解
- NB-T 47013.15-2021 承壓設(shè)備無損檢測(cè) 第15部分:相控陣超聲檢測(cè)
- 10KV供配電工程施工組織設(shè)計(jì)
- 終端攔截攻略
- 藥物外滲處理及預(yù)防【病房護(hù)士安全警示教育培訓(xùn)課件】--ppt課件
- 紙箱檢驗(yàn)標(biāo)準(zhǔn)新
評(píng)論
0/150
提交評(píng)論